Treating pregnant women with the hormone progesterone can help stop them giving birth too early, is now believed to be ineffective.

TOP INSIGHT
Vaginal progesterone therapy may help reduce the risk for premature birth in cases of short cervix and if it is the first baby while, progesterone shots are given for later pregnancies.
A new trial involving more than 1,200 women - the largest ever conducted to assess the therapy - indicates that while the treatment is harmless, it does nothing to reduce the risk of premature birth.
Researchers recruited women who were considered to be at an increased risk of premature delivery, either because they had previously given birth to a pre-term baby or because they had lost a baby late in pregnancy.
Half the women were given progesterone while the rest received a dummy "placebo" pill.
The team found that treatment with progesterone made no difference in premature birth rates and offered no notable health benefit either to mothers or babies.
"This study will be an important resource for any future guideline revision, and we anticipate incorporation of the data provided by the new study into an overview of existing studies of the use of vaginal progesterone, which will assist in providing the best advice to women and those caring for them."
MEDINDIA




Email





